Emergency Medicine Reports - January 6, 2008

Target Audience:

This CME activity is intended for emergency physicians and family physicians.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is approved by the American College of Emergency Physicians for 2.3 hours of ACEP Category 1 credits.

Faculty

Editors
Sandra M. Schneider, MD
Professor
Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, New York

J. Stephan Stapczynski, MD
Chair
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

Peer Reviewers
Catherine A. Marco, MD, FACEP
Professor, Department of Surgery
Division of Emergency Medicine
University of Toledo College of Medicine
Toledo, OH and

Steven M. Winograd, MD, FACEP

Attending Physician, Emergency Medicine
Horton Hill Hospital
Middleton, NY
Arden Hill Hospital
Goshen, NY.

Author
Jonathan Glauser, MD, FACEP
Department of Emergency Medicine
Cleveland Clinic
Cleveland, OH

CME Question Reviewer
Roger Farel, MD
Retired
Newport Beach, CA

Subjects:

  • Thrombocytopenia

Objectives:

  • Recognize or increase index of suspicion for specific conditions
  • State the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed.
  • Discuss the differential diagnosis of the entity discussed.
  • Explain both likely and rare complications that may occur.

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that J. Stephan Stapczynski, MD (editor) serves on the speakers bureau for Pfizer. Roger Farel, MD (CME question reviewer) owns stock in Johnson & Johnson. Jonathan Glauser, MD, FACEP (author), Catherine A. Marco, MD, FACEP (peer reviewer), Steven M. Winograd, MD, FACEP (peer reviewer), and Sandra M. Schneider, MD (editor) report no relationships with companies related to the field of study covered by this CME activity.

Copyright 2008 AHC Media. All rights reserved.